Prime Therapeutics LLC, a pharmacy benefit manager (PBM), has named Christine Bent as its chief operating officer, it was reported yesterday.
The company says that Bent is to lead Prime's efforts to create the PBM of the future, working with the nation's leading Blues plans to put caregivers and patients in a position to optimise health through advances in pharmacy management.
Prior to Prime Therapeutics LLC, Bent was serving as senior vice president of operations at Allina Hospital and Clinics. She has also held executive operational roles at Minnesota-based Minneapolis Heart Institute and Atrius Health in Massachusetts.
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'